Joel Greenblatt's ACHC Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 435,950 shares of Acadia Healthcare Company, Inc. (ACHC) worth $10.79 M, representing 0.05% of the portfolio. First purchased in 2016-Q4, this long-term strategic position has been held for 36 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in ACHC, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2017, adding 499,032 shares. Largest reduction occurred in Q2 2017, reducing 622,597 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Acadia Healthcare Company (ACHC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Acadia Healthcare Company (ACHC) Trades by Joel Greenblatt
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2016 | +290,572 | New Buy | 290,572 | $33.10 |
| Q1 2017 | +499,032 | Add 171.74% | 789,604 | $43.60 |
| Q2 2017 | -622,597 | Reduce 78.85% | 167,007 | $49.38 |
| Q3 2017 | -29,801 | Reduce 17.84% | 137,206 | $47.76 |
| Q4 2017 | -137,206 | Sold Out | 137,206 | $0.00 |
| Q3 2018 | +31,731 | New Buy | 31,731 | $35.20 |
| Q4 2018 | -31,731 | Sold Out | 31,731 | $0.00 |
| Q1 2021 | +16,608 | New Buy | 16,608 | $57.14 |
| Q2 2021 | +22,949 | Add 138.18% | 39,557 | $62.74 |
| Q3 2021 | +3,847 | Add 9.73% | 43,404 | $63.77 |
| Q4 2021 | +7,253 | Add 16.71% | 50,657 | $60.70 |
| Q1 2022 | -9,203 | Reduce 18.17% | 41,454 | $65.52 |
| Q2 2022 | -16,674 | Reduce 40.22% | 24,780 | $67.64 |
| Q3 2022 | +1,672 | Add 6.75% | 26,452 | $78.18 |
| Q4 2022 | -6,122 | Reduce 23.14% | 20,330 | $82.32 |
| Q1 2023 | +9,477 | Add 46.62% | 29,807 | $72.25 |
| Q2 2023 | +5,645 | Add 18.94% | 35,452 | $79.64 |
| Q3 2023 | -9,026 | Reduce 25.46% | 26,426 | $70.31 |
| Q4 2023 | -14,678 | Reduce 55.54% | 11,748 | $77.76 |
| Q1 2024 | +1,504 | Add 12.80% | 13,252 | $79.22 |
| Q2 2024 | -4,534 | Reduce 34.21% | 8,718 | $67.54 |
| Q3 2024 | -8,718 | Sold Out | 8,718 | $0.00 |
| Q4 2024 | +157,461 | New Buy | 157,461 | $39.65 |
| Q1 2025 | -157,461 | Sold Out | 157,461 | $0.00 |
| Q2 2025 | +88,310 | New Buy | 88,310 | $22.69 |
| Q3 2025 | +347,640 | Add 393.66% | 435,950 | $24.76 |
Joel Greenblatt's Acadia Healthcare Company Investment FAQs
Joel Greenblatt first purchased Acadia Healthcare Company, Inc. (ACHC) in Q4 2016, acquiring 290,572 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Acadia Healthcare Company, Inc. (ACHC) for 36 quarters since Q4 2016. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's largest addition to Acadia Healthcare Company, Inc. (ACHC) was in Q1 2017, adding 789,604 shares worth $34.43 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 435,950 shares of Acadia Healthcare Company, Inc. (ACHC), valued at approximately $10.79 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Acadia Healthcare Company, Inc. (ACHC) represents approximately 0.05% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's peak holding in Acadia Healthcare Company, Inc. (ACHC) was 789,604 shares, as reported at the end of Q1 2017. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.